Revenue | ₹3.47Cr |
Net Profits | ₹-1.50Cr |
Net Profit Margins | -43.23% |
Vista Pharmaceuticals Ltd’s revenue jumped 7.43% since last year same period to ₹3.47Cr in the Q4 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated 29.48% jump in its revenue since last 3-months.
Vista Pharmaceuticals Ltd’s net profit fell -1766.67% since last year same period to ₹-1.50Cr in the Q4 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated -13.64% fall in its net profits since last 3-months.
Vista Pharmaceuticals Ltd’s net profit margin fell -1651.39% since last year same period to -43.23% in the Q4 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated 12.23% jumped in its net profit margins since last 3-months.
The revenue for Vista Pharmaceuticals Ltd in the Q4 results 2024 was ₹3.47Cr.
The net profit for Vista Pharmaceuticals Ltd in the Q4 results 2024 was ₹-1.50Cr.
The net profit margin for Vista Pharmaceuticals Ltd in the Q4 results 2024 was -43.23%.
The revenue for Vista Pharmaceuticals Ltd in the Q4 results 2023 was ₹3.23Cr.
The net profit for Vista Pharmaceuticals Ltd in the Q4 results 2023 was ₹0.09Cr.
The net profit margin for Vista Pharmaceuticals Ltd in the Q4 results 2023 was 2.79%.